healthy subjects – Page 2 – Communicable Diseases Research

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines

mRNA 백신 추가 접종 후 활성 요법을 받는 암 환자의 SARS-CoV-2 감염

Article

Published on 2022-08-012022-09-11
Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

SARS-CoV-2 변이체에 대한 살균 면역을 유도할 수 있는 접힌 수용체 결합 도메인-PreS 융합 단백질 기반 백신

Article

Published on 2022-08-012022-09-11
Journal: Allergy [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus antibody Antibody Response Antigen C-terminus carrier cellular combination vaccine construction convalescent coronavirus COVID-19 COVID-19 pandemic fused fusion protein Genetic genotypes HBV healthy subject healthy subjects hepatitis B Hepatitis B virus human cell human cells IgG IgG antibodies IgG antibody IgG response Immunity immunized in vitro in vivo induce inhibited Interaction maintenance median mucosal secretions Neutralizing Neutralizing antibodies neutralizing antibody neutralizing titers Omicron variant pandemic Protein random Random sample RBD RBD-specific IgG RBD-specific IgG response receptor ACE2 Receptor binding Receptor-binding domain recombinant fusion protein Registered replicate respiratory response responsible robust SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant SARS-CoV-2 variants serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specific antibodies specific IgG antibodies spike Spike protein sterilizing immunity subject subjects subunit Subunit vaccine surface antigen sustained Vaccine Viral viral replication virus entry virus-neutralizing VNT
[DOI] 10.1111/all.15305 PMC 바로가기 [Article Type] Article

Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine

Pfizer-BioNTech mRNA 백신 접종 여부에 관계없이 중등도에서 중증 COVID-19 환자 및 건강한 피험자의 말초혈 면역 세포 프로필

Article

Published on 2022-07-112022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료기술,

[키워드] acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive analyzed B cell B cells Blood causative agent caused CD14 CD16 CD19 CD19+ CD3+ CD4+ CD4+ T cells CD4+ T lymphocyte CD56 CD56+ CD8+ T cell CD8+ T cells clinical manifestations coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients detectable determine dysregulated flow cytometry Frequency group healthy control healthy subject healthy subjects HLA-DR host response immune Immune cell immune cells immune response Inflammatory Kuwait lymphocyte Lymphocyte subset Lymphocyte subsets Lymphocytes moderate moderate to severe monocyte monocyte subsets Monocytes mRNA mRNA vaccine NK cell NK cells no symptom no symptoms percentage percentages peripheral Peripheral blood Perturbation perturbations Pfizer Pfizer-BioNTech profile profiles PROTECT required respiratory SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe disease significantly higher significantly lower subjects subset T cells T lymphocytes the patient three group three groups vaccination was performed with COVID-19
[DOI] 10.3389/fimmu.2022.851765 PMC 바로가기 [Article Type] Article

T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine

B 세포 림프종 환자에서 COVID-19 mRNA 백신을 여러 번 접종한 후 SARS-CoV-2 및 Omicron 변이체에 대한 T 세포 반응

Case Reports

Published on 2022-07-012022-09-11
Journal: Journal for immunotherapy of cancer [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Antibody Response B cell B cells CD4 CD8 COVID-19 COVID-19 infections develop disease severity dose expected healthy subject healthy subjects Hematologic malignancy hematologic neoplasms humoral Immune escape immune system immunology Immunosuppression implication initial Lymphocytes lymphoma Messenger RNA mRNA mRNA vaccine multiple dose Neoplasms omicron Patient Patients with cancer protective immunity response SARS-CoV-2 SARS-CoV-2 virus T cell T cell response T cells T-lymphocytes the patient the SARS-CoV-2 virus the vaccine vaccination Vaccination strategy Vaccine Vaccines variant Viral Viral transmission while
[DOI] 10.1136/jitc-2022-004953 PMC 바로가기 [Article Type] Case Reports

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence

염증성 장 질환 환자의 코로나19 백신에 대한 SARS-CoV-2 감염 및 면역 반응의 위험: 현재 증거

Review

Published on 2022-06-232022-09-11
Journal: Frontiers in Immunology [Category] 변종,

[키워드] aberrant immune response Affect available data bowel Combination condition Corticosteroid Corticosteroids Course COVID-19 COVID-19 vaccine COVID-19 vaccines Crohn's disease Crohn’s disease current disease dysregulated environmental factors Factor forms healthy subjects IBD immune immune response immunogenicity Immunosuppressant immunosuppressants increased risk infection with SARS-CoV-2 infections Inflammatory Inflammatory bowel disease inflammatory bowel diseases intestinal intestinal disease less majority many case many cases measure modify Necrosis occur pandemic Pathogens Patient patients treated PROTECT Psychological psychological factors question receive reduce reduced response risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants significantly increased subject susceptibility susceptibility to infection susceptible individual therapy ulcerative colitis Vaccine
[DOI] 10.3389/fimmu.2022.933774 PMC 바로가기 [Article Type] Review

Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients

Research article

Published on 2022-06-012022-10-05
Journal: Metabolism: clinical and experimental [Category] 바이오마커, 진단, 치료기술,

The potential impact of COVID-19 on thyroid gland volumes among COVID-19 survivors

COVID-19 생존자의 갑상선 양에 대한 COVID-19의 잠재적 영향

Article

Published on 2022-06-012022-09-11
Journal: Endocrine [Category] COVID19(2023년), SARS, 치료기술,

Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients

부분 메틸화된 HeyL 프로모터는 이집트 COVID-19 환자의 심각한 질병을 예측합니다

Article

Published on 2022-05-312022-09-12
Journal: Disease Markers [Category] MERS, 진단,

[키워드] addition alteration America approved Asia association binding Biomarkers Blood blood sample Cell cell proliferation cells clinical outcomes COVID-19 COVID-19 patient COVID-19 patients CpG demethylating agent Diseases DNA DNA sequencing dose downstream dry cough Effect element environmental factor epithelial Europe facilitate Fever Frequency GenBank genetic material Health healthy subject healthy subjects illness IMPROVE incidence methylated Methylation Modification mortality rate Notch PCR Prognostic marker promoter reference sequence Regulation Regulatory severe pneumonia subject therapy transcription factor Treatment protocol unmethylated Vaccine
[DOI] 10.1155/2022/6780710 PMC 바로가기 [Article Type] Article

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese

백신을 접종한 일본인에서 SARS-CoV-2 뉴클레오캡시드, 스파이크 및 중화 항체 검출

Article

Published on 2022-05-052022-09-11
Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody Antibody titers coronavirus correlated detection detection system Efficacy Efficiency Elecsy Elecsys evaluate evaluated Fujirebio healthy subject healthy subjects IgG investigated Japanese Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody titer neutralizing antibody titers nucleocapsid patients with COVID-19 respiratory Roche SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 N sensitivity sera serological test severe acute respiratory syndrome Coronavirus specificity spike vaccination were assessed
[DOI] 10.3390/v14050965 PMC 바로가기 [Article Type] Article

In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection

COVID-19 혈청에 의해 유도된 체외 NET-osis는 백신 접종을 하지 않은 환자의 심각한 임상 경과 및 돌발성 감염의 면역 조절 장애와 관련이 있습니다.

Article

Published on 2022-05-042022-09-11
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 치료기술, 치료법, 치료제,

[키워드] ACE Activation affected age approach Breakthrough infection breakthrough infections CD14 CD16 CD3 CD4 CD4+ CD45 CD45RA CD45RO CD64 CD8 CD8+ Cell cells characterized circulating cytokine circulating cytokines classical Clinical course Clinical features complex Concentration controls COVID-19 COVID-19 infections COVID-19 patient COVID-19 patients COVID-19 sera COVID-19 treatment cytokine Cytokines Cytometry disease disease severity dysregulation effector cells expansion healthy healthy donors healthy subject healthy subjects highlight Hospital admission IFN-γ IL-17A IL-1β IL-6 immune Immune cell immune cells immune dysregulation immune response In-vitro inhibitor Inpatients Major marker memory B-cell Mild Mild disease moderate Monocytes myeloid naïve NET NETosis NETs neutrophil Neutrophil extracellular trap overexpressing Patient patients percentage Peripheral blood pilot study ramipril reduced reduction risk sera severe COVID-19 patient Sex T cell T cells T-cell T-cells Treatment viral clearance
[DOI] 10.1038/s41598-022-11157-0 PMC 바로가기 [Article Type] Article